3I6K
Newly identified epitope from SARS-CoV membrane protein complexed with HLA-A*0201
Summary for 3I6K
Entry DOI | 10.2210/pdb3i6k/pdb |
Descriptor | HLA class I histocompatibility antigen, A-2 alpha chain, Beta-2-microglobulin, Membrane glycoprotein peptide, ... (4 entities in total) |
Functional Keywords | hla-a2, sars-cov, membrane glycoprotein, disulfide bond, glycoprotein, host-virus interaction, immune response, membrane, mhc i, phosphoprotein, transmembrane, disease mutation, glycation, immunoglobulin domain, pyrrolidone carboxylic acid, secreted, envelope protein, golgi apparatus, viral matrix protein, virion, immune system |
Biological source | Homo sapiens (human) More |
Cellular location | Membrane; Single-pass type I membrane protein: P01892 Secreted: P61769 |
Total number of polymer chains | 6 |
Total formula weight | 89481.61 |
Authors | |
Primary citation | Liu, J.,Sun, Y.,Qi, J.,Chu, F.,Wu, H.,Gao, F.,Li, T.,Yan, J.,Gao, G.F. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes J Infect Dis, 202:1171-1180, 2010 Cited by PubMed Abstract: Severe acute respiratory syndrome coronavirus (SARS-CoV), which emerged with highly contagious and life-threatening characteristics in 2002, remains a potential risk for future outbreaks. Membrane (M) and envelope (E) proteins are major structural proteins of the SARS-CoV. The M protein has been determined as a protective antigen in humoral responses. However, its potential roles in stimulating cellular immunity remain elusive. PubMed: 20831383DOI: 10.1086/656315 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.8 Å) |
Structure validation
Download full validation report